Kestra Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$546K	Buy	6,303 +571	+10%	+$50K	﹤0.01%	2147
2025 Q4	$486K	Buy	5,732 +1,012	+21%	+$80.8K	﹤0.01%	2164
2025 Q3	$342K	Sell	4,720 -70	-1%	-$4.83K	﹤0.01%	2339
2025 Q2	$314K	Sell	4,790 -474	-9%	-$30.9K	﹤0.01%	2313
2025 Q1	$371K	Buy	5,264 +139	+3%	+$9.66K	﹤0.01%	2017
2024 Q4	$337K	Sell	5,125 -207	-4%	-$14.2K	﹤0.01%	2148
2024 Q3	$377K	Sell	5,332 -95	-2%	-$6.62K	﹤0.01%	1947
2024 Q2	$360K	Buy	5,427 +591	+12%	+$38.7K	﹤0.01%	2006
2024 Q1	$328K	Buy	4,836 +78	+2%	+$5.16K	﹤0.01%	1937
2023 Q4	$294K	Buy	4,758 +105	+2%	+$6.17K	﹤0.01%	1859
2023 Q3	$274K	Sell	4,653 -186	-4%	-$11.4K	﹤0.01%	1723
2023 Q2	$289K	Buy	4,839 +543	+13%	+$32.3K	﹤0.01%	1643
2023 Q1	$251K	Sell	4,296 -411	-9%	-$24.8K	﹤0.01%	1682
2022 Q4	$292K	Buy	4,707 +117	+3%	+$7.04K	﹤0.01%	1762
2022 Q3	$259K	Sell	4,590 -351	-7%	-$21.6K	﹤0.01%	1692
2022 Q2	$316K	Buy	4,941 +258	+6%	+$16.4K	﹤0.01%	1587
2022 Q1	$303K	Buy	4,683 +33	+0.7%	+$2.09K	﹤0.01%	1586
2021 Q4	$309K	Sell	4,650 -741	-14%	-$47K	﹤0.01%	1583
2021 Q3	$329K	Buy	5,391 +1,386	+35%	+$88.1K	﹤0.01%	1610
2021 Q2	$248K	Buy	4,005 +12	+0.3%	+$730	﹤0.01%	1705
2021 Q1	$237K	Sell	3,993 -1,254	-24%	-$75.6K	﹤0.01%	1614
2020 Q4	$312K	Buy	+5,247	New	+$299K	﹤0.01%	1452